Skip to the page

Data / Form D filings / Nemus

Nemus: Form D filings

Nemus, a pharmaceuticals company in Costa Mesa, CA, filed 2 Form D notices with the SEC in 2014. The latest, on October 20, 2014, reports $455,100 sold of a $455,100 offering to 18 investors.

Find out what Nemus does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
650 Town Center Drive, Suite 620, Costa Mesa, CA, 92626
Phone
(310) 948-2274
Industry
Pharmaceuticals
Entity type
Corporation
Incorporated in
California
Year incorporated
2012
Revenue range
No Revenues
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1611294

The full lists. Form D filings in California: 5,891 rows, $138.91, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Oct 20, 2014New notice$455,100$455,100$018Oct 7, 2014sec.gov
Jun 27, 2014New notice$2,000,000$1,486,000$514,00012Jun 13, 2014sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Elizabeth BereczExecutive Officer
Cosmas LykosExecutive Officer, Director
Reg LaphamPromoter
John HollisterExecutive Officer, Director
Brian MurphyExecutive Officer
Jerry McLaughlinDirector

Other pharmaceuticals companies in California that filed recently

Every Form D from the week of Oct 20, 2014 · All recent filings in California · All recent Pharmaceuticals filings

Read from SEC EDGAR. Amount sold is what Nemus reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.

$10 of credit on sign-up, no card.